Inspire(US:INSP) Prnewswire·2025-11-25 13:45Core Viewpoint - Inspire Medical Systems, Inc. is facing a class action lawsuit due to alleged securities fraud related to the poor launch of its new product, Inspire V, which was marked by significant operational failures and misrepresentations to investors [3]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors affected by alleged securities fraud between August 6, 2024, and August 4, 2025 [2]. - Defendants are accused of making false statements and concealing the poor demand for Inspire V, as providers had excess inventory and were hesitant to adopt the new treatment [3]. - Key operational failures included incomplete training for treatment center customers, lack of necessary IT systems, and failure to secure Medicare reimbursement prior to the product launch [3]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until January 5, 2026, to request appointment as lead plaintiff, although participation does not require this role [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [4]. Group 3: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [5]. - The firm is recognized as one of the top securities litigation firms in the United States, with extensive expertise in complex cases [5].